Cargando…
Enhancing MicroRNA Activity through Increased Endosomal Release Mediated by Nigericin
The therapeutic promise of small-RNA therapeutics is limited, not only by the lack of delivery vehicles, but also by the inability of the small RNAs to reach intracellular compartments where they can be biologically active. We previously reported successful delivery of functionally active miRNAs via...
Autores principales: | Orellana, Esteban A., Abdelaal, Ahmed M., Rangasamy, Loganathan, Tenneti, Srinivasarao, Myoung, Sunghyun, Low, Philip S., Kasinski, Andrea L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506612/ https://www.ncbi.nlm.nih.gov/pubmed/31071527 http://dx.doi.org/10.1016/j.omtn.2019.04.003 |
Ejemplares similares
-
MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy
por: Orellana, Esteban A., et al.
Publicado: (2015) -
Approach to nigericin derivatives and their therapeutic potential
por: Sahu, Amit Kumar, et al.
Publicado: (2020) -
A perspective to weaponize microRNAs against lung cancer
por: Murugan, Dhanashree, et al.
Publicado: (2022) -
Nigericin Promotes NLRP3-Independent Bacterial Killing in Macrophages
por: Armstrong, Heather, et al.
Publicado: (2019) -
A potassium ionophore (Nigericin) inhibits stimulation of human lymphocytes by mitogens
Publicado: (1978)